TOLERO PHARMACEUTICALS, INC.

Basic Information

2975 W. Executive Parkway
Suite 320
Lehi, UT, 84043

Company Profile

n/a

Additional Details

Field Value
DUNS: 969849004
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 20


  1. TARGETING BMP SIGNALING WITH TP-0413

    Amount: $200,000.00

    TP-0413 is a novel small molecule inhibitor of the BMP pathway that has significant potential to be developed to treat anemia of cancer. Anemia of cancer is cytokine driven and results in the up-regul ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government